Newsroom

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitizing and automating workflows to deliver intelligent operations, will showcase its latest AI-driven hardware, software, and services at NRF 2026: Retail’s Big Show. Zebra’s solutions will be featured in Booth #3303 from Jan. 11–13, 2026 at the Jacob K. Javits Convention Center in New York City. As retailers navigate a competitive landscape, they face growing pressures to meet rising cons...

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News :  Au titre du contrat de liquidité confié par emeis (Paris:EMEIS) (la “Société”) à Natixis Oddo BHF, les moyens suivants figuraient au compte de liquidité dédié au 31 décembre 2025. - Nombre d’actions : 70 965 - Solde en espèces : 1 111 687 € Au cours du second semestre 2025, il a été négocié un total de : ACHAT 1 513 transactions 1 158 608 actions 15 241 520,04 € VENTE 1 604 transactions 1 165 917 actions 15 456 925,47 € Il est rappelé que lor...

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Under the liquidity agreement entrusted by emeis (Paris:EMEIS) (the “Company”) to Natixis Oddo BHF, the following resources were recorded in the dedicated liquidity account as of 31 December 2025. - 70,965 shares - €1,111,687 in cash During the 2025 second half-year, it was carried out a total of: PURCHASE 1,513 transactions 1,158,608 shares €15,241,520.04 SALE 1,604 transactions 1,165,917 shares €15,456,925.47 It is reminded that as of the las...

LYON, France--(BUSINESS WIRE)--Regulatory News: Conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers (« AMF »), ADOCIA SA, 115, avenue Lacassagne, 69003 Lyon (Euronext Paris : FR0011184241 – ADOC – la « Société »), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques innovantes pour le traitement du diabète et de l’obésité, pu...

LYON, France--(BUSINESS WIRE)--Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French “Code de Commerce” and article 223-16 of the General Regulation of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”), ADOCIA SA, a French société anonyme (corporation), 115, avenue Lacassagne, 69003 Lyon (Euronext Paris: FR0011184241 – ADOC) a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic soluti...

NEW YORK--(BUSINESS WIRE)--BitGo Holdings Inc. (“BitGo”), the digital asset infrastructure company, today announced that it supported iPower Inc. (Nasdaq: IPW) in the execution and custody of its digital asset treasury transactions. iPower completed purchases of Bitcoin (BTC) and Ethereum (ETH) through an account maintained at BitGo Bank & Trust, National Association (“BitGo Bank & Trust”). The transactions were executed using BitGo Prime’s over-the-counter (OTC) trading services, enabl...

PARIS--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Paris:ALMKT): Listing: Euronext Growth Paris ISIN code: FR0010609263, Ticker: ALMKT Website: www.maunakeatech.com Date Number of shares comprising the capital in circulation Total number of voting rights Gross Total (1) Net Total (2) December 31, 2025 177,693,455 178,776,992 178,776,992 (1) The gross number of voting rights (or "theoretical" voting rights) serves as the basis for calculating the thresholds. In accordance with Arti...

PARIS--(BUSINESS WIRE)--Regulatory News : Mauna Kea Technologies (Paris:ALMKT): Place de cotation : Euronext Growth Paris Code ISIN : FR0010609263, Mnémonique : ALMKT Site web : www.maunakeatech.com Date Nombre de titres composant le capital en circulation Nombre total de droits de vote Total Brut (1) Total net (2) 31 décembre 2025 177 693 455 178 776 992 178 776 992 (1) Le nombre de droits de vote bruts (ou droits de vote « théoriques ») sert de base de calcul pour les franchissements de seuil...

RALEIGH, N.C.--(BUSINESS WIRE)--Advance Auto Parts Names OSRAM Sylvania Inc. Global 2025 Vendor Partner of the Year...

ESCONDIDO, Calif.--(BUSINESS WIRE)--Enthorin Therapeutics, LLC, a biotechnology company focused on circuit-modulating treatments for neurological and neurodevelopmental disorders, announced that its licensing partner for MRM-3379 (formerly ENT-3379), Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), in December, reported the initiation of the BLOOM Phase 2 clinical study evaluating MRM-3379 in Fragile X syndrome (FXS). MRM-3379 is an orally available, highly brain-penetrant, selective phosphodiestera...